These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30252610)

  • 1. Evidence-Based Medicine in Otolaryngology Part 9: Valuing Health Outcomes.
    Caulley L; Hunink MG; Kilty S; Metha V; Scangas G; Rodin D; Randolph G; Shin JJ
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):11-21. PubMed ID: 30252610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valuation of health-related quality of life and utilities in health economics].
    Greiner W; Klose K
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):120-5. PubMed ID: 24780709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Based Medicine in Otolaryngology Part 10: Cost-Effectiveness Analyses in Otolaryngology.
    Caulley L; Rodin D; Kilty S; Randolph G; Hunink MG; Shin JJ
    Otolaryngol Head Neck Surg; 2019 Sep; 161(3):375-387. PubMed ID: 31184254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis and otolaryngology.
    Hamilton D; Hulme C; Flood L; Powell S
    J Laryngol Otol; 2014 Feb; 128(2):112-8. PubMed ID: 24507161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state valuation in low- and middle-income countries: a systematic review of the literature.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Value Health; 2013; 16(6):1091-9. PubMed ID: 24041360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preference-based measures in economic evaluation in health care.
    Neumann PJ; Goldie SJ; Weinstein MC
    Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-adjusted life-years. Ethical implications for physicians and policymakers.
    La Puma J; Lawlor EF
    JAMA; 1990 Jun; 263(21):2917-21. PubMed ID: 2110986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of terminology and methodology in economic analyses in otolaryngology.
    Kezirian EJ; Yueh B
    Otolaryngol Head Neck Surg; 2001 May; 124(5):496-502. PubMed ID: 11337651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?
    Brazier JE; Rowen D; Lloyd A; Karimi M
    Value Health; 2019 Jan; 22(1):62-68. PubMed ID: 30661635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies.
    Jackson LJ; Auguste P; Low N; Roberts TE
    Value Health; 2014; 17(1):116-30. PubMed ID: 24438725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of health status instruments.
    Chen AY; Whigham AS
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(4):167-72. PubMed ID: 15467340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes research: an overview.
    Stewart MG
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(4):163-6. PubMed ID: 15467339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?
    Tengs TO
    Value Health; 2004; 7(1):70-8. PubMed ID: 14720132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
    Goodwin E; Green C
    Value Health; 2015 Dec; 18(8):1016-24. PubMed ID: 26686786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.